Presented by: Dan Some, Ph.D., Wyatt Technology
Presented Live: October 26, 2017
Aggregation and stability are important criteria for selecting biotherapeutic candidates for developability and optimizing their formulation. Screening of the broadest matrix of conditions and excipients enables true QbD, imparting confidence in the ultimate choice of candidates and formulations with which to move forward.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.